An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots

Status unconfirmed · Phase 1 · Has a placebo group

Conditions studied: HIV Infections

In brief

This study will assess the distribution of a microbicidal gel in the vagina and confirm the presence of bare spots. MRIs will be done with and without the addition of the MRI contrast Gadolinium to the microbicide in order to determine whether the bare spots are an artifact of the MRI technique.

Key facts

Study ID

NCT00214812

Run by

Biosyn

People needed

6

Starts

2005-06-01

Last updated by the study team

2005-10-25

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• 18 -45 year old women
• normal Pap smear
• not pregnant

You may not qualify if…

• abnormal pelvic exam
• history of claustrophobia
• allergy to product formulation
• pregnant or breastfeeding

Where it is running

• Reproductive Research Unit, U of Penn Medical Center — Philadelphia, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.